These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26152128)

  • 1. Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription.
    Lloret-Linares C; Bellivier F; Haffen E; Aubry JM; Daali Y; Heron K; Berney P; Desmeules J; Besson M
    Curr Drug Metab; 2015; 16(1):17-45. PubMed ID: 26152128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current topics in pharmacokinetics and pharmacogenetics of antidepressant drugs].
    Gex-Fabry M; Bertschy G; Kosel M; Ferrero F
    Rev Med Suisse; 2009 Sep; 5(217):1808, 1810-3. PubMed ID: 19839368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants.
    Oz MD; Ozdemir F; Suzen HS
    Curr Drug Metab; 2021; 22(8):596-627. PubMed ID: 33243113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants and drug-metabolizing enzymes--expert group report.
    Meyer UA; Amrein R; Balant LP; Bertilsson L; Eichelbaum M; Guentert TW; Henauer S; Jackson P; Laux G; Mikkelsen H; Peck C; Pollock BG; Priest R; Sjöqvist F; Delini-Stula A
    Acta Psychiatr Scand; 1996 Feb; 93(2):71-9. PubMed ID: 8686486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F; Eliasson E
    Clin Pharmacol Ther; 2007 Jun; 81(6):899-902. PubMed ID: 17392719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for therapeutic monitoring of antidepressants].
    Baumann P; Rougemont M; Corruble E; Hiemke C;
    Rev Med Suisse; 2013 Mar; 9(377):577-86. PubMed ID: 23534245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study).
    Lloret-Linares C; Daali Y; Chevret S; Nieto I; Molière F; Courtet P; Galtier F; Richieri RM; Morange S; Llorca PM; El-Hage W; Desmidt T; Haesebaert F; Vignaud P; Holtzmann J; Cracowski JL; Leboyer M; Yrondi A; Calvas F; Yon L; Le Corvoisier P; Doumy O; Heron K; Montange D; Davani S; Déglon J; Besson M; Desmeules J; Haffen E; Bellivier F
    BMC Pharmacol Toxicol; 2017 Nov; 18(1):70. PubMed ID: 29115994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
    Kirchheiner J; Nickchen K; Bauer M; Wong ML; Licinio J; Roots I; Brockmöller J
    Mol Psychiatry; 2004 May; 9(5):442-73. PubMed ID: 15037866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of antidepressant pharmacokinetics and pharmacogenetics.
    Cohen LJ; De Vane CL
    Ann Pharmacother; 1996 Dec; 30(12):1471-80. PubMed ID: 8968460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic testing and personalized treatment of depression.
    Perlis RH
    Clin Chem; 2014 Jan; 60(1):53-9. PubMed ID: 24281779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.
    Jha MK; Trivedi MH
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29329256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine.
    Jackson KD; Achour B; Lee J; Geffert RM; Beers JL; Latham BD
    Drug Metab Dispos; 2023 Oct; 51(10):1238-1253. PubMed ID: 37419681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy.
    Hefner G; Laib AK; Sigurdsson H; Hohner M; Hiemke C
    Int Rev Psychiatry; 2013 Oct; 25(5):494-508. PubMed ID: 24151798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.
    Burke MJ; Preskorn SH
    Clin Pharmacokinet; 1999 Aug; 37(2):147-65. PubMed ID: 10496302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.
    Porcelli S; Fabbri C; Spina E; Serretti A; De Ronchi D
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1101-15. PubMed ID: 21736534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics in depression and antidepressants.
    Bondy B
    Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.